Tingxuan Wang

Qingdao University

Papers

1

Total Citations

4

H-Index

1

About

Tingxuan Wang is a leading researcher in neurosurgical innovation, with a primary focus on minimally invasive treatments for cerebral hemorrhage. Their most cited work, a 2025 study comparing ROSA robot-assisted stereotactic surgery with craniotomy and neuroendoscopy, has already garnered 4 citations, demonstrating its immediate impact. This research provides critical evidence that robot-assisted techniques can improve hematoma evacuation precision while reducing surgical trauma, directly addressing a major challenge in managing basal ganglia hemorrhages. Wang’s contributions are pivotal in advancing stereotactic robotics and neuroendoscopy, offering safer, more effective alternatives to traditional open surgery. Their work not only enhances patient outcomes but also sets a benchmark for future clinical trials in neurotrauma. By systematically evaluating these surgical modalities, Wang has established a framework for personalized treatment selection, influencing both clinical practice and surgical robotics development. Their findings are essential reading for neurosurgeons and researchers seeking to optimize hemorrhage management, highlighting Wang’s role as a key innovator in translating robotic technology into life-saving neurosurgical care.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Efficacy and Prognosis of ROSA Robot-Assisted Stereotactic Intracranial Hematoma Removal in Patients with Cerebral Hemorrhage in Basal Ganglia Region: Comparison with Craniotomy and Neuroendoscopy
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Qingdao University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago